An updated methodology to review developing-country vaccine manufacturer viability (Q39365283)

30 September 2017

5 references

20 June 2019

22 October 2019

2 October 2020

5 October 2020

24 January 2021

An updated methodology to review developing-country vaccine manufacturer viability (English)

1 reference

30 September 2017

1 reference

22 October 2019

1 reference

2 October 2020

1 reference

5 October 2020

1 reference

24 January 2021

Nicholas Luter

1

1 reference

30 September 2017

Ritu Kumar

2

1 reference

30 September 2017

Dai Hozumi

3

1 reference

30 September 2017

Tina Lorenson

4

1 reference

30 September 2017

Shannon Larsen

5

1 reference

30 September 2017

Bhavya Gowda

6

1 reference

30 September 2017

Amie Batson

7

1 reference

30 September 2017

language of work or name

English

0 references

publication date

8 June 2017

1 reference

30 September 2017

5 July 2017

5 references

20 June 2019

22 October 2019

2 October 2020

5 October 2020

24 January 2021

6 references

30 September 2017

20 June 2019

22 October 2019

2 October 2020

5 October 2020

24 January 2021

35

1 reference

30 September 2017

31

1 reference

30 September 2017

3897-3903

1 reference

Creative Commons Attribution 4.0 International

30 September 2017

5 references

20 June 2019

22 October 2019

2 October 2020

5 October 2020

Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.

24 January 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Impact of BRICS' investment in vaccine development on the global vaccine market

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Lessons learned during the development and transfer of technology related to a new Hib conjugate vaccine to emerging vaccine manufacturers

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Twenty-five years of the WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Economical value of vaccines for the developing countries--the case of Instituto Butantan, a public institution in Brazil.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Reaching international GMP standards for vaccine production: challenges for developing countries

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Vaccine quality--can a single standard be defined?

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

New challenges in assuring vaccine quality

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Global DTP manufacturing capacity and capability. Status report: January 1995.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

Benefits from immunization during the vaccines for children program era - United States, 1994-2013.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

During the 'decade of vaccines,' the lives of 6.4 million children valued at $231 billion could be saved.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5593149

A systematic method for evaluating the potential viability of local vaccine producers

21 August 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.087

Access to vaccine technologies in developing countries: Brazil and India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.087

Lock in, the state and vaccine development: Lessons from the history of the polio vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.087

The Meningitis Vaccine Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.087

Vaccine Supply: Effects Of Regulation And Competition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.04.087

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2017.04.087

1 reference

30 September 2017

1 reference

30 September 2017

PubMed publication ID

28602604

1 reference